Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07527286 · ClinicalTrials.gov registry record
The Effects of a Postbiotic Supplement on Biomarkers of Gut Health
A clinical trial, sponsored by Verb Biotics.
- Completed
- Registry status
- 76
- Enrollment target
NCT07527286 is a clinical trial that has completed, run by Verb Biotics. The registered enrollment target is 76 participants.
The verdict
NCT07527286 has completed, sponsored by Verb Biotics.
- COMPLETED
- Registry status
- 76 participants
- Enrollment target
Study Summary
This study is a randomized, double-blind, two-arm, placebo-controlled trial of N=80 (40/arm) apparently healthy men and women between 18 and 65 years old to be recruited at a single investigational center in Northeast Ohio (i.e., The Center for Applied Health Sciences). This study will assess the effectiveness of a postbiotic supplement on various biomarkers of health. Consumption of this dietary supplement is not intended to diagnose, treat, cure, or prevent any disease. Participants will attend three in-person study visits. During Visit 1, participants will be screened for participation (i.e., medical history, routine blood work, background baseline diet). Over the next 4 weeks, participants will attend two in-person visits: \[visit 2 (week 0) and visit 3 (week 4)\] wherein assessments of gut function \[fecal microbiome diversity, short chain fatty acids (SCFA), and fecal butyrate\], serum butyrate, serum zonulin, salivary cortisol, and Gastrointestinal Symptom Rating Scale (GSRS) for gastrointestinal (GI) health, emotional states \[Depression, Anxiety and Stress Scale (DASS21)\], and quality of life (SF-36 questionnaire) will be assessed. Participants will also be provided home kits with instructions on how to collect stool and saliva samples on two separate occasions (i.e., visit 2, visit 3) during the study. • Comprehensive side effect profile/ adverse event monitoring will take place throughout the study duration. The study will be conducted following ICH-GCP guidelines to ensure participant safety and scientific integrity of the data.
Interventions
- DIETARY_SUPPLEMENT Postbiotic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2024-11-05 |
| Est. Completion | 2025-04-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07527286
The ClinicalTrials.gov registry entry for NCT07527286 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Verb Biotics, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Postbiotic is the first listed.
NCT07527286 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07527286 about?
NCT07527286 is a clinical study titled "The Effects of a Postbiotic Supplement on Biomarkers of Gut Health". This study is a randomized, double-blind, two-arm, placebo-controlled trial of N=80 (40/arm) apparently healthy men and women between 18 and 65 years old to be recruited at a single investigational center in Northeast Ohio (i.e., The Center for Applied Health Sciences). This study will assess the e...
What is the current status of trial NCT07527286?
This trial is currently completed. The enrollment target is 76 participants. The study started on 2024-11-05. Estimated completion is 2025-04-26.
What interventions are being tested in trial NCT07527286?
The interventions under investigation include: Postbiotic (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07527286?
This trial is sponsored by Verb Biotics, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.